New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareThymosin Beta-4 vs Melanotan 1

Thymosin Beta-4 vs Melanotan 1

Side-by-side comparison of key properties, dosing, and research.

Recovery & RepairAnti-Aging & Longevity
Thymosin Beta-4
Skin & CosmeticSexual Health & Libido
Melanotan 1
Summary
Thymosin Beta-4 is an endogenous 43-amino acid peptide that is the primary intracellular actin sequestering peptide. It promotes tissue repair, reduces inflammation, regenerates hair follicles, and protects cardiac tissue. Closely related to TB-500 (the active fragment), it is used for systemic tissue recovery and anti-aging.
Melanotan 1 (Afamelanotide) is a synthetic analog of α-MSH that selectively stimulates melanogenesis (tanning) through MC1R activation. It provides UV-independent skin pigmentation and is FDA/EMA-approved under the name SCENESSE for erythropoietic protoporphyria (EPP) and vitiligo.
Half-Life
Not well characterized; likely similar to TB-500 (~1–2 hours)
~40–60 minutes (free peptide); implant formulation (SCENESSE) releases over months
Admin Route
SubQ, IM
SubQ
Research
Typical Dose
5–10 mg
0.5–1 mg
Frequency
2x per week (loading), then 1x per week (maintenance)
Daily until desired color achieved, then maintenance
Key Benefits
  • Systemic tissue repair and regeneration
  • Promotes cardiac recovery after myocardial infarction
  • Hair follicle regeneration and anti-hair-loss
  • Anti-inflammatory (systemic)
  • Wound healing acceleration
  • Neuroprotection after brain injury
  • Protects against ischemia-reperfusion injury
  • Anti-aging at cellular level
  • Synergizes powerfully with BPC-157
  • Induces skin pigmentation/tanning without UV exposure
  • Provides photoprotection in photosensitivity conditions (EPP)
  • FDA-approved for erythropoietic protoporphyria (SCENESSE)
  • Approved in EU for EPP treatment
  • Anti-inflammatory via MC1R
  • Mild libido enhancement
  • Potential skin cancer prevention through melanin protection
Side Effects
  • Generally very well tolerated
  • Injection site reactions
  • Mild fatigue at initiation (repair signaling)
  • Rare: mild inflammatory response
  • +1 more
  • Nausea (especially at higher doses)
  • Facial flushing
  • Fatigue
  • Injection site reactions
  • +3 more
Stacks With